Elsevier

Biochemical Pharmacology

Volume 43, Issue 9, 8 May 1992, Pages 1957-1961
Biochemical Pharmacology

Research paper
Mefloquine metabolism by human liver microsomes: Effect of other antimalarial drugs

https://doi.org/10.1016/0006-2952(92)90638-YGet rights and content

Abstract

A number of drugs have been studied for their effect on the metabolism of the antimalarial drug mefloquine by human liver microsomes (N = 6) in vitro. The only metabolite generated was identified as carboxymefloquine by co-chromatography with the authentic standard. Ketoconazole caused marked inhibition of carboxymefloquine formation with ic50 and Ki values of 7.5 and 11.2 μM, respectively. The inhibition by ketoconazole, a known inhibitor of cytochrome P450 isozymes, and the dependency of metabolite formation on the presence of NADPH indicated that cytochrome P450 isozyme(s) catalysed metabolite production. Of compounds actually or likely to be coadministered with mefloquine to malaria patients only primaquine and quinine produced marked inhibition (ic50, 17.5 and 122 μM; Ki, 8.6 and 28.5 μM, respectively). However, despite these in vitro data with primaquine, clinical studies have failed to show any significant effect of single dose primaquine on the pharmacokinetics of mefloquine. With quinine, because peak plasma concentrations are very close to the Ki value, there is likely to be inhibition of mefloquine metabolism in patients receiving both drugs. Sulfadoxine, artemether, artesunate and tetracycline did not significantly inhibit carboxymefloquine formation.

References (37)

  • A. Resetar et al.

    Glucuronidation of 3′-azido-3′-deoxythymidine catalysed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics

    Biochem Pharmacol

    (1991)
  • H.K. Webster et al.

    Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand

    Am J Trop Med Hyg

    (1985)
  • J. Karbwang et al.

    Clinical importance of antimalarial pharmacokinetics

    Asia Pac J Pharmacol

    (1988)
  • J.M. DeSouza et al.

    Single dose kinetics of mefloquine in Brazilian male subjects

    Bull WHO

    (1987)
  • G. Franssen et al.

    Divided dose kinetics of mefloquine in man

    Br J Clin Pharmacol

    (1989)
  • D.E. Schwartz et al.

    Kinetic studies of mefloquine and one of its metabolites Ro 21-5104 in the dog and in man

    Acta Tropica

    (1980)
  • J.Y. Mu et al.

    Studies of the disposition and metabolism of mefloquine HCL (WR 142 490) a quinoline methanol antimalarial in the rat

    Drug Metab Dispos

    (1975)
  • R.S. Rozman et al.

    The absorption distribution and excretion in mice of the antimalarial mefloquine erythro-2,8-bis(trifluoromethyl)-(2-piperidyl)-4-quinolinemethanol hydrochloride

    Drug Metab Dispos

    (1978)
  • Cited by (43)

    • Approach to the Patient with HIV and Coinfecting Tropical Infectious Diseases

      2011, Tropical Infectious Diseases: Principles, Pathogens and Practice
    • In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors

      2009, Acta Tropica
      Citation Excerpt :

      However, it is not known whether or to what extent the increased mefloquine efflux is associated with increased susceptibility to the drug, or whether other mechanisms are also involved. Mefloquine has been shown both in vitro and in vivo to be biotransformed by the liver enzyme cytochrome P450 (CYP) to an inactive product, carboxymefloquine (Na-Bangchang et al., 1992; Na-Bangchang et al., 2007). Although there is no direct evidence to support the existence of CYP in P. falciparum, we have previously provided indirect evidence for the possibility of the involvement of CYP-mediated metabolism of mefloquine in P. falciparum clones by the ability of the parasite to biotransform mefloquine to carboxymefloquine and an unidentified metabolite (Na-Bangchang et al., 2007).

    • Approach to the Patient with HIV and Coinfecting Tropical Infectious Diseases

      2005, Tropical Infectious Diseases: Principles, Pathogens, & Practice, 2-Volume Set with CD-ROM
    View all citing articles on Scopus
    View full text